Syra Health Corp. Class A Common Stock
SYRA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | -$0 | -$0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -13.3% | 4.8% | -7.4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 32.9% | 38.7% | 31.7% | 22.7% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -13.1% | -2.8% | -24.9% | -24.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -13.4% | -3.3% | -25.4% | -25.1% |
| EPS Diluted | -0.019 | -0.01 | -0.065 | -0.069 |
| % Growth | -89% | 84.6% | 6.3% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | $0 | -$0 |